Search results

Found 5,185 pages
AUTHOR: Kevin Grogan

3 Aug 2012:

Pfizer sells Sandwich site

Pfizer has finally found a buyer for its Sandwich site in Kent, having completed the sale to a private consortium. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/pfizer_sells_sandwich_site_976851

19 Sep 2013:

Skyepharma's Flutiform in COPD trials

The UK’s Skyepharma says that partner Mundipharma has commenced an international clinical trial of the firms’ asthma drug Flutiform for the treatment of chronic obstructive pulmonary disease.  - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/skyepharmas_flutiform_in_copd_trials_1005720

9 May 2014:

Europe approval for GSK/Theravance COPD drug

GlaxoSmithKline and partner Theravance are celebrating after the European Commission granted marketing authorisation for their chronic obstructive pulmonary disease Anoro. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/europe_approval_for_gsktheravance_copd_drug_1001914

18 Oct 2013:

FDA employees return to work

FDA employees return to work - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/fda_employees_return_to_work_1005871

4 Feb 2015:

Genmab multiple myeloma drug shines in Phase II

Genmab and partner Johnson & Johnson have been boosted by positive mid-stage data on daratumumab for multiple myeloma. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/genmab_multiple_myeloma_drug_shines_in_phase_ii_970988

22 Nov 2011:

UCB acquires Lectus assets

UCB has acquired the key pharmaceutical assets of the UK's Lectus Therapeutics, boosting its efforts in the central nervous system field. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/ucb_acquires_lectus_assets_980012

22 May 2013:

Europe approves Baxter/Halozyme's HyQvia

The European Commission has given the green light to Baxter International and Halozyme Therapeutics' HyQvia as replacement therapy for adults with primary and secondary immunodeficiencies. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/europe_approves_baxterhalozymes_hyqvia_1005059

9 May 2014:

Icon seals acquisition of Aptiv

Ireland-based clinical research organisation giant Icon has completed its $143.5 million acquisition of Aptiv Solutions. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/icon_seals_acquisition_of_aptiv_1001917

9 Jul 2012:

Bayer progress on long-acting haemophilia drug

Bayer has started to enroll patients in an international Phase II/III trial to evaluate a new treatment for haemophilia A. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/bayer_progress_on_long-acting_haemophilia_drug_976999

12 Jul 2010:

Roche signs neurological pact with UK’s MRC

Roche’s Genentech unit has entered into an agreement with MRC Technology for an exclusive licence to a series of small molecule drug candidates for the potential treatment of neurological disease. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/roche_signs_neurological_pact_with_uks_mrc_982946